News
European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback